Probiotics: Shaping the gut immunological responses
- PMID: 38681982
- PMCID: PMC11045475
- DOI: 10.3748/wjg.v30.i15.2096
Probiotics: Shaping the gut immunological responses
Abstract
Probiotics are live microorganisms exerting beneficial effects on the host's health when administered in adequate amounts. Among the most popular and adequately studied probiotics are bacteria from the families Lactobacillaceae, Bifidobacteriaceae and yeasts. Most of them have been shown, both in vitro and in vivo studies of intestinal inflammation models, to provide favorable results by means of improving the gut microbiota composition, promoting the wound healing process and shaping the immunological responses. Chronic intestinal conditions, such as inflammatory bowel diseases (IBD), are characterized by an imbalance in microbiota composition, with decreased diversity, and by relapsing and persisting inflammation, which may lead to mucosal damage. Although the results of the clinical studies investigating the effect of probiotics on patients with IBD are still controversial, it is without doubt that these microorganisms and their metabolites, now named postbiotics, have a positive influence on both the host's microbiota and the immune system, and ultimately alter the topical tissue microenvironment. This influence is achieved through three axes: (1) By displacement of potential pathogens via competitive exclusion; (2) by offering protection to the host through the secretion of various defensive mediators; and (3) by supplying the host with essential nutrients. We will analyze and discuss almost all the in vitro and in vivo studies of the past 2 years dealing with the possible favorable effects of certain probiotic genus on gut immunological responses, highlighting which species are the most beneficial against intestinal inflammation.
Keywords: Bifidobacteriaceae; Immune responses; Intestinal inflammation; Lactobacillaceae; Probiotics; Saccharomyces.
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Figures

Similar articles
-
The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.Microbiol Spectr. 2015 Jun;3(3). doi: 10.1128/microbiolspec.MBP-0008-2014. Microbiol Spectr. 2015. PMID: 26185088
-
Microbes, intestinal inflammation and probiotics.Expert Rev Gastroenterol Hepatol. 2012 Feb;6(1):81-94. doi: 10.1586/egh.11.94. Expert Rev Gastroenterol Hepatol. 2012. PMID: 22149584 Review.
-
Anti-Inflammatory and Immunomodulatory Effects of Probiotics in Gut Inflammation: A Door to the Body.Front Immunol. 2021 Feb 26;12:578386. doi: 10.3389/fimmu.2021.578386. eCollection 2021. Front Immunol. 2021. PMID: 33717063 Free PMC article. Review.
-
Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease.Front Immunol. 2020 Sep 11;11:2144. doi: 10.3389/fimmu.2020.02144. eCollection 2020. Front Immunol. 2020. PMID: 33042125 Free PMC article. Review.
-
The role of the microbiome in gastrointestinal inflammation.Biosci Rep. 2021 Jun 25;41(6):BSR20203850. doi: 10.1042/BSR20203850. Biosci Rep. 2021. PMID: 34076695 Free PMC article.
Cited by
-
Relevance of Glucagon-Like Peptide 1 (GLP-1) in Inflammatory Bowel Diseases: A Narrative Review.Curr Issues Mol Biol. 2025 May 21;47(5):383. doi: 10.3390/cimb47050383. Curr Issues Mol Biol. 2025. PMID: 40699782 Free PMC article. Review.
-
The impact of probiotics on glycemic control during the first 3 months after sleeve gastrectomy: a prospective placebo‑controlled study.Wideochir Inne Tech Maloinwazyjne. 2025 Jul 4;20(2):190-195. doi: 10.20452/wiitm.2025.17968. eCollection 2025 Jul 8. Wideochir Inne Tech Maloinwazyjne. 2025. PMID: 40785742 Free PMC article.
-
Probiotics and Food Bioactives: Unraveling Their Impact on Gut Microbiome, Inflammation, and Metabolic Health.Probiotics Antimicrob Proteins. 2025 Jan 14. doi: 10.1007/s12602-025-10452-2. Online ahead of print. Probiotics Antimicrob Proteins. 2025. PMID: 39808399 Review.
-
Efficacy of Probiotics in the Management of Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.Cureus. 2024 Dec 18;16(12):e75954. doi: 10.7759/cureus.75954. eCollection 2024 Dec. Cureus. 2024. PMID: 39830577 Free PMC article. Review.
-
Therapeutic Potential of Probiotics: A Review of Their Role in Modulating Inflammation.Probiotics Antimicrob Proteins. 2025 Jun 4. doi: 10.1007/s12602-025-10609-z. Online ahead of print. Probiotics Antimicrob Proteins. 2025. PMID: 40465090
References
-
- Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S, Calder PC, Sanders ME. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11:506–514. - PubMed
-
- Hotel ACP, Cordoba A. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Prev. 2001;5:1–10.
-
- Sanders ME, Merenstein D, Merrifield CA, Hutkins R. Probiotics for human use. Nutrit Bull. 2018;43:212–225.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous